Cipher Historical Balance Sheet

CPH Stock

CAD 13.32 0.29 2.13%

Trend analysis of Cipher Pharmaceuticals balance sheet accounts such as Short Long Term Debt Total of 301.8 K, Other Current Liabilities of 280.8 K or Total Current Liabilities of 10.3 M provides information on Cipher Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Cipher Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Cipher Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Cipher Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cipher Pharmaceuticals is a good buy for the upcoming year.

Cipher Pharmaceuticals Inventory

3.6 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cipher Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Cipher Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Cipher Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Cipher Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cipher Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cipher currently owns. An asset can also be divided into two categories, current and non-current.

Cipher Pharmaceuticals Balance Sheet Chart

At this time, Cipher Pharmaceuticals' Accounts Payable is very stable compared to the past year. As of the 6th of February 2025, Cash is likely to grow to about 48.1 M, while Short and Long Term Debt Total is likely to drop about 301.8 K.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Cipher Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cipher Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Cipher Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Cipher Pharmaceuticals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Cipher Pharmaceuticals' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Cipher Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cipher Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	428K	353K	317.7K	301.8K
Total Assets	73.8M	86.0M	98.9M	103.9M

Short Long Term Debt Total Total Assets

Cipher Pharmaceuticals balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets
Total Assets		0.42	0.17	0.34	0.82	-0.14	-0.45	-0.33	0.74	0.34	0.85	0.88	0.43	0.82	0.85	0.2	0.2	0.39	0.78	0.44	-0.56	0.38	-0.07	0.77	0.41	0.39
Short Long Term Debt Total	0.42		0.69	0.62	-0.14	-0.07	-0.26	0.57	0.03	0.53	0.17	0.38	0.35	-0.03	0.17	0.45	-0.12	0.99	-0.07	0.86	-0.04	0.94	-0.12	0.44	0.97	0.85
Other Current Liab	0.17	0.69		0.85	-0.34	-0.03	-0.37	0.55	-0.09	0.65	0.05	0.0	0.37	-0.2	0.05	0.61	-0.15	0.71	-0.22	0.52	-0.09	0.84	-0.09	0.38	0.65	0.39
Total Current Liabilities	0.34	0.62	0.85		-0.15	-0.03	-0.33	0.49	0.12	0.75	0.08	0.21	0.23	-0.11	0.08	0.74	-0.06	0.61	-0.12	0.58	-0.35	0.83	-0.09	0.44	0.55	0.48
Total Stockholder Equity	0.82	-0.14	-0.34	-0.15		-0.09	-0.31	-0.72	0.78	-0.06	0.82	0.75	0.24	0.94	0.82	-0.18	0.29	-0.18	0.93	-0.04	-0.53	-0.21	0.02	0.5	-0.12	-0.06
Property Plant And Equipment Net	-0.14	-0.07	-0.03	-0.03	-0.09		-0.24	0.17	-0.13	-0.34	-0.24	-0.03	-0.27	-0.24	-0.24	-0.1	-0.11	-0.12	-0.15	-0.07	-0.2	-0.09	0.99	-0.21	0.01	-0.04
Current Deferred Revenue	-0.45	-0.26	-0.37	-0.33	-0.31	-0.24		-0.01	-0.43	-0.08	-0.29	-0.48	0.12	-0.32	-0.29	-0.01	-0.26	-0.2	-0.47	-0.21	0.52	-0.27	-0.28	-0.32	-0.37	-0.14
Net Debt	-0.33	0.57	0.55	0.49	-0.72	0.17	-0.01		-0.39	0.25	-0.66	-0.12	-0.08	-0.71	-0.66	0.33	-0.28	0.56	-0.64	0.6	0.14	0.61	0.06	-0.33	0.59	0.63
Retained Earnings	0.74	0.03	-0.09	0.12	0.78	-0.13	-0.43	-0.39		0.3	0.59	0.73	0.15	0.77	0.59	0.2	0.27	-0.03	0.83	0.12	-0.86	0.0	-0.06	0.45	0.03	0.09
Accounts Payable	0.34	0.53	0.65	0.75	-0.06	-0.34	-0.08	0.25	0.3		0.23	0.1	0.39	0.05	0.23	0.91	-0.12	0.55	-0.06	0.52	-0.3	0.68	-0.37	0.56	0.4	0.4
Cash	0.85	0.17	0.05	0.08	0.82	-0.24	-0.29	-0.66	0.59	0.23		0.57	0.51	0.89	1.0	0.05	0.18	0.17	0.79	0.06	-0.31	0.12	-0.16	0.78	0.14	-0.01
Non Current Assets Total	0.88	0.38	0.0	0.21	0.75	-0.03	-0.48	-0.12	0.73	0.1	0.57		0.23	0.69	0.57	-0.04	0.23	0.32	0.75	0.51	-0.6	0.29	0.03	0.44	0.44	0.53
Non Currrent Assets Other	0.43	0.35	0.37	0.23	0.24	-0.27	0.12	-0.08	0.15	0.39	0.51	0.23		0.34	0.51	0.2	-0.3	0.38	0.23	0.23	0.01	0.34	-0.25	0.45	0.29	0.18
Other Assets	0.82	-0.03	-0.2	-0.11	0.94	-0.24	-0.32	-0.71	0.77	0.05	0.89	0.69	0.34		0.89	-0.11	0.43	-0.06	0.91	-0.05	-0.47	-0.11	-0.14	0.59	-0.02	-0.08
Cash And Short Term Investments	0.85	0.17	0.05	0.08	0.82	-0.24	-0.29	-0.66	0.59	0.23	1.0	0.57	0.51	0.89		0.05	0.18	0.17	0.79	0.06	-0.31	0.12	-0.16	0.78	0.14	-0.01
Net Receivables	0.2	0.45	0.61	0.74	-0.18	-0.1	-0.01	0.33	0.2	0.91	0.05	-0.04	0.2	-0.11	0.05		-0.14	0.47	-0.25	0.47	-0.31	0.62	-0.16	0.44	0.29	0.34
Common Stock Shares Outstanding	0.2	-0.12	-0.15	-0.06	0.29	-0.11	-0.26	-0.28	0.27	-0.12	0.18	0.23	-0.3	0.43	0.18	-0.14		-0.14	0.28	-0.16	-0.22	-0.12	-0.07	0.12	-0.1	-0.12
Non Current Liabilities Total	0.39	0.99	0.71	0.61	-0.18	-0.12	-0.2	0.56	-0.03	0.55	0.17	0.32	0.38	-0.06	0.17	0.47	-0.14		-0.13	0.85	0.04	0.95	-0.17	0.45	0.95	0.83
Inventory	0.78	-0.07	-0.22	-0.12	0.93	-0.15	-0.47	-0.64	0.83	-0.06	0.79	0.75	0.23	0.91	0.79	-0.25	0.28	-0.13		-0.08	-0.58	-0.17	-0.05	0.43	-0.01	-0.1
Other Current Assets	0.44	0.86	0.52	0.58	-0.04	-0.07	-0.21	0.6	0.12	0.52	0.06	0.51	0.23	-0.05	0.06	0.47	-0.16	0.85	-0.08		-0.09	0.83	-0.12	0.31	0.84	0.96
Other Stockholder Equity	-0.56	-0.04	-0.09	-0.35	-0.53	-0.2	0.52	0.14	-0.86	-0.3	-0.31	-0.6	0.01	-0.47	-0.31	-0.31	-0.22	0.04	-0.58	-0.09		-0.1	-0.25	-0.34	-0.04	-0.08
Total Liab	0.38	0.94	0.84	0.83	-0.21	-0.09	-0.27	0.61	0.0	0.68	0.12	0.29	0.34	-0.11	0.12	0.62	-0.12	0.95	-0.17	0.83	-0.1		-0.15	0.5	0.88	0.78
Property Plant And Equipment Gross	-0.07	-0.12	-0.09	-0.09	0.02	0.99	-0.28	0.06	-0.06	-0.37	-0.16	0.03	-0.25	-0.14	-0.16	-0.16	-0.07	-0.17	-0.05	-0.12	-0.25	-0.15		-0.14	-0.03	-0.08
Total Current Assets	0.77	0.44	0.38	0.44	0.5	-0.21	-0.32	-0.33	0.45	0.56	0.78	0.44	0.45	0.59	0.78	0.44	0.12	0.45	0.43	0.31	-0.34	0.5	-0.14		0.35	0.24
Short Term Debt	0.41	0.97	0.65	0.55	-0.12	0.01	-0.37	0.59	0.03	0.4	0.14	0.44	0.29	-0.02	0.14	0.29	-0.1	0.95	-0.01	0.84	-0.04	0.88	-0.03	0.35		0.85
Intangible Assets	0.39	0.85	0.39	0.48	-0.06	-0.04	-0.14	0.63	0.09	0.4	-0.01	0.53	0.18	-0.08	-0.01	0.34	-0.12	0.83	-0.1	0.96	-0.08	0.78	-0.08	0.24	0.85

Click cells to compare fundamentals

Cipher Pharmaceuticals Account Relationship Matchups

Cipher Pharmaceuticals balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	44.3M	51.7M	73.8M	86.0M	98.9M	103.9M
Short Long Term Debt Total	1.8M	516K	428K	353K	317.7K	301.8K
Other Current Liab	4.5M	5.2M	450K	257K	295.6K	280.8K
Total Current Liabilities	9.9M	12.3M	9.4M	5.3M	6.0M	10.3M
Total Stockholder Equity	32.6M	38.9M	64.1M	80.5M	92.6M	97.2M
Property Plant And Equipment Net	1.9M	501K	481K	402K	462.3K	640.4K
Current Deferred Revenue	307K	450K	257K	519K	467.1K	714.3K
Net Debt	(7.3M)	(20.0M)	(28.4M)	(39.5M)	(35.5M)	(33.7M)
Retained Earnings	18.4M	25.2M	50.5M	66.3M	76.2M	80.0M
Accounts Payable	1.6M	5.6M	4.1M	4.6M	5.3M	5.6M
Cash	9.1M	20.5M	28.8M	39.8M	45.8M	48.1M
Non Current Assets Total	24.1M	22.3M	35.6M	37.8M	43.4M	45.6M
Non Currrent Assets Other	(21.8M)	(19.9M)	(18.9M)	19.9M	17.9M	18.8M
Other Assets	943K	2.4M	2.5M	16.7M	19.2M	20.1M
Cash And Short Term Investments	9.1M	20.5M	28.8M	39.8M	45.8M	48.1M
Net Receivables	9.2M	6.7M	6.8M	5.1M	5.9M	8.6M
Common Stock Shares Outstanding	27.4M	26.8M	107.5M	25.4M	29.2M	32.1M
Liabilities And Stockholders Equity	44.3M	51.7M	73.8M	86.0M	98.9M	103.9M
Non Current Liabilities Total	1.7M	460K	327K	259K	297.9K	283.0K
Inventory	892K	1.7M	2.2M	3.0M	3.4M	3.6M
Other Current Assets	875K	471K	371K	378K	434.7K	864.0K
Other Stockholder Equity	5.1M	5.1M	5.4M	5.8M	5.2M	4.9M
Total Liab	11.6M	12.8M	9.7M	5.5M	6.3M	6.0M
Property Plant And Equipment Gross	1.9M	641K	716K	756K	869.4K	686.7K
Total Current Assets	20.1M	29.3M	38.2M	48.3M	55.5M	27.9M
Short Term Debt	137K	56K	101K	94K	108.1K	102.7K
Intangible Assets	4.2M	3.6M	2.8M	1.8M	2.0M	1.9M
Common Stock	18.7M	18.1M	17.7M	18.0M	16.2M	14.7M
Net Tangible Assets	1.9M	12.8M	19.5M	45.6M	41.1M	43.1M
Property Plant Equipment	2.2M	1.9M	501K	481K	553.2K	788.2K
Long Term Debt Total	1.8M	1.7M	460K	327K	294.3K	279.6K
Capital Surpluse	5.0M	5.1M	5.1M	5.4M	6.2M	5.6M
Net Invested Capital	32.6M	38.9M	64.1M	80.5M	92.6M	52.7M
Net Working Capital	10.2M	17.0M	28.8M	43.0M	49.5M	51.9M

Pair Trading with Cipher Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cipher Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cipher Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving against Cipher Stock

0.53	ARA	Aclara Resources	Pair Corr
0.37	STC	Sangoma Technologies Corp	Pair Corr

The ability to find closely correlated positions to Cipher Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cipher Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cipher Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cipher Pharmaceuticals to buy it.

The correlation of Cipher Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cipher Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cipher Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Cipher Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Other Information on Investing in Cipher Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cipher Historical Balance Sheet

Cipher Pharmaceuticals Inventory

3.6 Million

About Cipher Balance Sheet Analysis

Cipher Pharmaceuticals Balance Sheet Chart

Total Assets

Total Current Liabilities

Cipher Pharmaceuticals balance sheet Correlations

Cipher Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cipher Pharmaceuticals balance sheet Accounts

Pair Trading with Cipher Pharmaceuticals

Moving against Cipher Stock

Other Information on Investing in Cipher Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net
Short Term Debt	+ 0.97	Short Long Term Debt Total
Intangible Assets	+ 0.96	Other Current Assets
Total Liab	+ 0.95	Non Current Liabilities Total

Other Stockholder Equity	- 0.86	Retained Earnings
Net Debt	- 0.72	Total Stockholder Equity
Other Assets	- 0.71	Net Debt
Cash And Short Term Investments	- 0.66	Net Debt
Cash	- 0.66	Net Debt
Inventory	- 0.64	Net Debt